HOME > ARCHIVE

ARCHIVE

COMMENTARY／Acetaminophen, 1st Step Forward Toward Better Pediatric Pharmacotherapy

January 22, 2007
Daiichi Pharm. Launches Sonazoid Ultrasound Contrast Agent

January 22, 2007
REGULATORY NEWS IN BRIEF

January 22, 2007
JSA to Propose Anti-stroke Measures

January 22, 2007
R&D NEWS IN BRIEF

January 15, 2007
10 Questions for the New Year

January 15, 2007
Asymptomatic Hepatitis B 57% : Bristol-Myers

January 15, 2007
Seminar

January 15, 2007
Korosho to Initiate "Purity Testing" Project for Generics

January 15, 2007
Blopress Remains Top Selling Drug for 3rd Year in a Row

January 15, 2007
GENERIC NEWS IN BRIEF

January 15, 2007
BUSINESS NEWS IN BRIEF

January 15, 2007
OPINION

January 15, 2007
Burgeoning Market for ARBs -Hot Battlefield for Megapharmas-

January 15, 2007
Constipation Does Not Increase Risk of Colorectal Cancer: Korosho Study Group

January 15, 2007
Korosho Committed to Promoting Innovation in Pharma Industry: Health Minister

January 15, 2007
Bile Acid Reflux Causes Gastric Ulcers, Cancer: Prof. Haruma

January 15, 2007
FPMAJ to Propose New Drug Pricing Rule: President Morita

January 15, 2007
NPhA to Focus on Its Incorporation, Increase in Membership

January 15, 2007
HPB's Budget Earmarks \90 Mil. to Fund Training of CRCs

January 15, 2007

ページ

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo OKs New CEA Handling, with Third-Party Verification Ahead

Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…

COMMENTARY

Are Technical Discussions Enough for Japan’s CEA System?

By Ken Yoshino

Japan is finally launching technical discussions on its cost-effectiveness assessment (CEA) system. A health ministry-funded research group is set to…

COLUMN

The Patient North Star: How Gilead Japan Redefined Innovation

By Philip Carrigan

In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…